Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
By T. J. Key, P. Appleby, G. Reeves, A. Roddam, J. Dorgan, C. Longcope, F. Stanczyk, H. E. Stephenson, R. Falk, R. Miller and 36 more. Journal of the National Cancer Institute, 2003
1,104 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/26e579e6a1a0f9f50a1e8494138b060bbb8b18c4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Picon-Ruiz
- K. Avgerinos
- A. Wolk
- C. Mantzoros
- C. Morata-Tarifa
- Nikolaos K. Spyrou
- S. Larsson
- Maria Dalamaga
Citations in the corpus
- Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention (2017, background): “Elevated serum sex steroid levels account for a large component of the excess risk of postmenopausal breast cancer among obese women.(174) Estrogen levels are”
- Obesity and cancer risk: Emerging biological mechanisms and perspectives. (2019, background): “Elevated blood concentrations of androgens have been associated with increased risk of BC in women regardless of menopausal status [89,90].”
- Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. (2007, background): “Adiposity is inversely related to testosterone concentrations in men (61–63) but positively related to testosterone concentrations in women (64, 65).”